Clear-eyed reviews of the claims, failures, regulatory signals and product-quality risks the marketing leaves out.
Our framework separates the question people want answered from the question a study actually tested—then keeps approval, safety and product quality in their own lanes.
Read the evidence field guideAnimal models, anecdotes and a compelling mechanism can create a strong story. They still do not establish human efficacy, a validated protocol or product quality.
Analysis preview →A single HPLC percentage cannot establish identity, net content, sterility, endotoxin control, custody or formulation stability.
Analysis preview →Regulatory categories, bulk-substance reviews and product approval are different questions. Blurring them creates false reassurance.
Analysis preview →Why target engagement, a phase 2 signal and an impressive chart can still collapse under larger trials, safety or an endpoint mismatch.
Analysis preview →A named stack is a new intervention. It cannot inherit the strongest study, safest component or approval status inside the vial.
Analysis preview →Community reports can surface questions. Without verification, controls and a denominator, they cannot quantify benefit or risk.
Analysis preview →